Study rejects link between digoxin, mortality risk in A-fib patients

04/18/2013 | MedPage Today (free registration)

Taking digoxin does not increase the risk of mortality, hospital admissions or incident nonfatal arrhythmia in patients with atrial fibrillation, according to a study published online in the European Heart Journal. Researchers analyzed data from the AFFIRM study and found no significant difference in rate of all-cause death between digoxin users and nonusers.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT